ImmunoPET for prostate cancer in the PSMA era: do we need other targets?

被引：0
|
作者：
Luca Filippi
Laura Evangelista
Mike M. Sathekge
Orazio Schillaci
机构：
[1] Santa Maria Goretti Hospital,Department of Nuclear Medicine
[2] University of Padua,Nuclear Medicine Unit, Department of Medicine (DIMED)
[3] University of Pretoria,Department of Nuclear Medicine
[4] Steve Biko Academic Hospital,Nuclear Medicine Research Infrastructure (NuMeRI)
[5] University Tor Vergata,Department of Biomedicine and Prevention
[6] IRCCS Neuromed,undefined
来源：
Clinical and Translational Imaging | 2022年 / 10卷
关键词：
ImmunoPET; Prostate cancer; Precision medicine; Castration-resistant prostate cancer; PET/CT; Theranostics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：587 / 596
页数：9
相关论文
共 50 条
  • [1] ImmunoPET for prostate cancer in the PSMA era: do we need other targets?
    Filippi, Luca
    Evangelista, Laura
    Sathekge, Mike M.
    Schillaci, Orazio
    CLINICAL AND TRANSLATIONAL IMAGING, 2022, 10 (06) : 587 - 596
  • [2] Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?
    Vetrone, Luigia
    Fortunati, Emilia
    Castellucci, Paolo
    Fanti, Stefano
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 150 - 162
  • [3] DO WE NEED A NEW TAXONOMY FOR PROSTATE CANCER?
    Rubin, M.
    ANNALS OF ONCOLOGY, 2014, 25
  • [4] Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review
    Gauthe, Mathieu
    Sargos, Paul
    Barret, Eric
    Fromont-Hankard, Gaelle
    Beauval, Jean-Baptiste
    Brureau, Laurent
    Crehange, Gilles
    Renard-Penna, Raphaele
    Dariane, Charles
    Fiard, Gaelle
    Mathieu, Romain
    Roubaud, Guilhem
    Ruffion, Alain
    Roupret, Morgan
    Ploussard, Guillaume
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [5] Do we need sigma constraints in era of intensity-modulated radiation therapy for prostate cancer?
    Patani, F.
    Fasciolo, D.
    Allajbej, A.
    Trignani, M.
    Di Tommaso, M.
    Augurio, A.
    Vinciguerra, A.
    Caravatta, L.
    Genovesi, D.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S622 - S623
  • [6] Do we need elective nodal irradiation in prostate cancer?
    Khoo, V.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S45 - S46
  • [7] Immunotherapy for metastatic prostate cancer: do we really need this?
    Heidenreich, A.
    UROLOGE, 2012, 51 (01): : 32 - 38
  • [8] Do we need PSA and early detection of prostate cancer?
    Abrahamsson, Per-Anders
    Tinzi, Martina
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (05) : 393 - 395
  • [9] Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?
    Russell, Beth
    Beyer, Katharina
    Lawlor, Ailbhe
    Roobol, Monique J.
    Venderbos, Lionne D. F.
    Remmers, Sebastiaan
    Briers, Erik
    MacLennan, Sara J.
    MacLennan, Steven
    Omar, Muhammad Imran
    Van Hemelrijck, Mieke
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 59 : 27 - 29
  • [10] ImmunoPET imaging of Trop2 for PSMA-Negative Prostate Cancer
    Long, X.
    Wei, W.
    Lan, X.
    Jiang, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S447 - S447
12345